tiprankstipranks
Trending News
More News >
Antengene Corporation Limited (HK:6996)
FRANKFURT:6996

Compare Antengene Corporation Limited (6996) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Antengene Corporation Limited
HK$5.27
HK$2.68B
-11.24
494.37%
0 Buy
1 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$12.33
HK$12.49B
-44.18
311.44%
1 Buy
1 Hold
0 Sell
Moderate Buy
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$1.93B
238.10
38.89%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$1.90B
-2.69
-52.12%
SinoMab Bioscience Ltd.
HK$1.39
HK$2.35B
-11.90
72.73%
Immunotech Biopharm Ltd
HK$2.68
HK$1.71B
-6.43
29.32%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6996
Antengene Corporation Limited
4.22
3.52
502.86%
HK:1672
Ascletis Pharma, Inc.
12.59
9.41
295.91%
HK:1875
TOT BIOPHARM International Co. Ltd.
2.50
0.70
38.89%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
3.96
-4.31
-52.12%
HK:3681
SinoMab Bioscience Ltd.
1.71
0.71
71.00%
HK:6978
Immunotech Biopharm Ltd
2.77
0.70
33.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts